Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. [electronic resource]
Producer: 20060213Description: 8679-87 p. digitalISSN:- 0732-183X
- Adenocarcinoma -- genetics
- Aged
- Antimetabolites, Antineoplastic -- adverse effects
- Capecitabine
- Combined Modality Therapy
- Deoxycytidine -- adverse effects
- Dihydrouracil Dehydrogenase (NADP) -- genetics
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Female
- Fluorouracil -- analogs & derivatives
- Gene Expression Regulation, Neoplastic -- drug effects
- Hematologic Diseases -- etiology
- Humans
- Male
- Middle Aged
- Pancreatic Neoplasms -- genetics
- Radiotherapy, Adjuvant -- adverse effects
- Statistics as Topic
- Survival Analysis
- Thymidine Phosphorylase -- genetics
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.